Financials

  • Market Capitalization 15.47 M
  • Employee 6
  • Founded 2009
  • CEO N/A
  • Website www.kalarx.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2MVT8
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.17
Fiyat/satışlar oranı

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
4651
TPST
Tempest Therapeutics, Inc. - Common Stock
1.08 USD0.00%+6.93%+27.06%-54.81%15.99 M USD
4662
HIND
Vyome Holdings, Inc. - Common Stock
2.21 USD+2.79%0.00%+11.06%-76.39%15.51 M USD
4671
ADIL
Adial Pharmaceuticals, Inc - Common Stock
5.69 USD-4.21%-4.37%+98.26%+1358.97%14.94 M USD
4682
AEON
AEON Biopharma, Inc. Class A Common Stock
0.29 USD+16.00%+45.00%+11.54%-72.12%14.47 M USD

Haberler